Header Logo

Connection

Jimmy Ballard to Humans

Back to Details
This is a "connection" page, showing publications Jimmy Ballard has written about Humans.
Jimmy Ballard
Connection Strength
0.700
Humans
  1. A sequence invariable region in TcdB2 is required for toxin escape from Clostridioides difficile. J Bacteriol. 2024 07 25; 206(7):e0009624.
    View in: PubMed
    Score: 0.053
  2. Discovery of Hippo signaling as a regulator of CSPG4 expression and as a therapeutic target for Clostridioides difficile disease. PLoS Pathog. 2023 03; 19(3):e1011272.
    View in: PubMed
    Score: 0.049
  3. Presence and magnitude of anterior physeal separation in slipped upper femoral epiphysis helps identifying those at high risk for avascular necrosis. Injury. 2022 Dec; 53(12):4020-4027.
    View in: PubMed
    Score: 0.047
  4. Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination. Infect Immun. 2019 08; 87(8).
    View in: PubMed
    Score: 0.038
  5. Unique, Intersecting, and Overlapping Roles of C/EBP ß and CREB in Cells of the Innate Immune System. Sci Rep. 2018 11 16; 8(1):16931.
    View in: PubMed
    Score: 0.036
  6. Pathogens boosted by food additive. Nature. 2018 01 18; 553(7688):285-286.
    View in: PubMed
    Score: 0.034
  7. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate Clostridium difficile TcdB. mBio. 2017 05 16; 8(3).
    View in: PubMed
    Score: 0.032
  8. Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region. J Biol Chem. 2015 Mar 13; 290(11):6975-85.
    View in: PubMed
    Score: 0.028
  9. Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev. 2013 Dec; 77(4):567-81.
    View in: PubMed
    Score: 0.026
  10. Toxin inhibition of antimicrobial factors induced by Bacillus anthracis peptidoglycan in human blood. Infect Immun. 2013 Oct; 81(10):3693-702.
    View in: PubMed
    Score: 0.025
  11. Increased cAMP in monocytes augments Notch signaling mechanisms by elevating RBP-J and transducin-like enhancer of Split (TLE). J Biol Chem. 2013 Jul 26; 288(30):21526-36.
    View in: PubMed
    Score: 0.025
  12. Glycogen synthase kinase 3 activation is important for anthrax edema toxin-induced dendritic cell maturation and anthrax toxin receptor 2 expression in macrophages. Infect Immun. 2011 Aug; 79(8):3302-8.
    View in: PubMed
    Score: 0.021
  13. Medical microbiology: A toxin contest. Nature. 2010 Oct 07; 467(7316):665-6.
    View in: PubMed
    Score: 0.021
  14. Clostridium difficile infection. Am J Med Sci. 2010 Sep; 340(3):247-52.
    View in: PubMed
    Score: 0.020
  15. Clostridium sordellii toxic shock syndrome. Lancet Infect Dis. 2009 Dec; 9(12):725-6.
    View in: PubMed
    Score: 0.019
  16. Critical intermediate steps in Clostridium sordellii lethal toxin-induced apoptosis. Biochem Biophys Res Commun. 2007 Nov 30; 363(4):959-64.
    View in: PubMed
    Score: 0.017
  17. Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains of Clostridium sordellii. FEMS Microbiol Lett. 2006 Jun; 259(2):295-302.
    View in: PubMed
    Score: 0.015
  18. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005 Apr; 18(2):247-63.
    View in: PubMed
    Score: 0.014
  19. Clostridium sordellii lethal toxin is maintained in a multimeric protein complex. Infect Immun. 2004 Jun; 72(6):3366-72.
    View in: PubMed
    Score: 0.013
  20. Clostridioides difficile toxin B subverts germinal center and antibody recall responses by stimulating a drug-treatable CXCR4-dependent mechanism. Cell Rep. 2024 May 28; 43(5):114245.
    View in: PubMed
    Score: 0.013
  21. Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin. Infect Immun. 2003 Jun; 71(6):3294-301.
    View in: PubMed
    Score: 0.012
  22. Clostridium difficile toxin B activates dual caspase-dependent and caspase-independent apoptosis in intoxicated cells. Cell Microbiol. 2002 Jul; 4(7):425-34.
    View in: PubMed
    Score: 0.012
  23. Clostridioides difficile Toxin B Activates Group 3 Innate Lymphocytes. Infect Immun. 2022 04 21; 90(4):e0007322.
    View in: PubMed
    Score: 0.011
  24. Identification of ClpP Dual Isoform Disruption as an Antisporulation Strategy for Clostridioides difficile. J Bacteriol. 2022 02 15; 204(2):e0041121.
    View in: PubMed
    Score: 0.011
  25. pH-enhanced cytopathic effects of Clostridium sordellii lethal toxin. Infect Immun. 2001 Sep; 69(9):5487-93.
    View in: PubMed
    Score: 0.011
  26. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion. Infect Immun. 2001 Jan; 69(1):599-601.
    View in: PubMed
    Score: 0.010
  27. Recommendations for future university pandemic responses: What the first COVID-19 shutdown taught us. PLoS Biol. 2020 08; 18(8):e3000889.
    View in: PubMed
    Score: 0.010
  28. Human C. difficile toxin-specific memory B cell repertoires encode poorly neutralizing antibodies. JCI Insight. 2020 08 20; 5(16).
    View in: PubMed
    Score: 0.010
  29. Toxin-neutralizing antibodies elicited by naturally acquired cutaneous anthrax are elevated following severe disease and appear to target conformational epitopes. PLoS One. 2020; 15(4):e0230782.
    View in: PubMed
    Score: 0.010
  30. Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires. Front Immunol. 2018; 9:3064.
    View in: PubMed
    Score: 0.009
  31. Anthrax Vaccine Precipitated Induces Edema Toxin-Neutralizing, Edema Factor-Specific Antibodies in Human Recipients. Clin Vaccine Immunol. 2017 Nov; 24(11).
    View in: PubMed
    Score: 0.008
  32. Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B. Infect Immun. 2016 01; 84(1):194-204.
    View in: PubMed
    Score: 0.007
  33. The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax. J Cell Mol Med. 2013 Jul; 17(7):914-20.
    View in: PubMed
    Score: 0.006
  34. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function. Infect Immun. 2012 Dec; 80(12):4374-87.
    View in: PubMed
    Score: 0.006
  35. Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity. Vaccine. 2011 May 09; 29(20):3670-8.
    View in: PubMed
    Score: 0.005
  36. Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge. J Infect Dis. 2010 Jul 15; 202(2):251-60.
    View in: PubMed
    Score: 0.005
  37. Resistance of human alveolar macrophages to Bacillus anthracis lethal toxin. J Immunol. 2009 Nov 01; 183(9):5799-806.
    View in: PubMed
    Score: 0.005
  38. Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin. Clin Infect Dis. 1994 Oct; 19(4):761-4.
    View in: PubMed
    Score: 0.002
  39. Synthesis and possible applications of biotin-linked copper clusters. Physiol Chem Phys Med NMR. 1990; 22(2):63-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.